HAIAF · Healthcare AI Acquisition Corp. · Metrics
$12.74
At close · Nov 14
Return incl. dividend (before tax)
Going-concern doubt
— flagged Nov 13, 2025
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt about the Company's ability to continue as a going concern for a reasonable period of time, which is considered to be one year from the issuance date of the financial statements.”View the 10-Q filed Nov 13, 2025
Market Cap
$70.62M
Shares
5.54M
Volume · Nov 14
94K
Avg daily vol (7 sessions)
16K
HAIAF metrics
31 of 122 screener metrics currently available.
Market overview
2 metricsShare price
$12.74
Market cap
$70.62M
Price action
20 metricsPrice change (1W)
—
Price change (30D)
—
Price change (3M)
+8.7%
Price change (6M)
—
Price change (YTD)
+11.5%
Price change (1Y)
+11.3%
Trailing year
Price change (5Y)
—
52-week high
$12.74
52-week low
$10.71
Change from 52-week high
+0.0%
Change from 52-week low
+19.0%
Annualized volatility
—
Annualized volatility (3M)
—
Beta
—
RSI (14D)
69.0
Price vs SMA 50
+9.4%
Price vs SMA 200
+13.5%
Avg volume (3M)
—
Relative volume
—
Average dollar volume
—
Company
3 metricsSector
Financial Services
Industry
Shell Companies
Shares outstanding
5.54M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
—
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-0.3%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
—
Profitability
9 metricsGross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
—
Operating profit (TTM)
−$661,302
Net income (TTM)
−$238,274
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
—
Year over year
Net income growth YoY
-472.2%
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
-4.3%
Year over year · fewer shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
—
Return on assets
-8.3%
Debt / equity
—
Current ratio
0.4
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
0.4
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$212
Latest balance sheet
Cash & equivalents
$212
Total assets
$2.86M
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$389,948
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—
Ownership (13F)
9 metrics13F filers
—
13F filer change QoQ
—
Institutional ownership
—
Conviction holders (share of 13F filers)
—
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
—
Holder tenure
—
Price vs estimated holder cost
—
Ownership (registered funds)
1 metricsIndex-fund ownership
0.0%
Short interest
3 metricsShort interest
0.0%
Latest settlement
Days to cover
—
Short-squeeze score
18 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
Flagged
Key facts
CIK
1848861